| abstract |
The present application discloses a composition comprising an agent (triptan (such as, for example, rizatriptan) and / or NSAID (such as, for example, meloxicam) together with cyclodextrin and / or carbonate or bicarbonate. Such compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the drug to treat conditions such as pain. [Selected figure] Figure 11 |